Skip to content

Effect of remimazolam combined with propofol on EEG and postoperative delirium in elderly patients

Effect of remimazolam combined with propofol on EEG and postoperative delirium in elderly patients

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046742
Enrollment
Unknown
Registered
2021-05-28
Start date
2021-06-05
Completion date
Unknown
Last updated
2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative delirium

Interventions

Group M:midazolam
Group R1:0.05mg/kg remimazolam
Group R2:0.1mg/kg remimazolam

Sponsors

The Second Hospital of Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. ASA: I-III; 2. Age: 65-75 years; 3. BMI: 19-27 kg/m^2; 4. Type of operation: laparoscopic radical prostatectomy or laparoscopic total cystectomy; 5. Anesthesia: general anesthesia tracheal intubation, operation time: estimated 3-4h; 6. Volunteer to participate in the study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. A history of epileptic seizures in the past month; 2. Suffer or have suffered from central nervous system disease; 3. NYHA classification: 3-4; 4. Patients who are allergic to or intolerant to midazolam or remazolam tosylate; 5. Long-term use of sedatives or antidepressants; 6. Patients with insufficient cerebral blood supply or syncope in the past month.

Design outcomes

Primary

MeasureTime frame
Electroencephalogram;Mean arterial pressure;Heart rate;Bispectral index;Modified observer’s assessment of alert /sedation scale;Delirium scale score;

Countries

China

Contacts

Public ContactDang Yaoyao

The Second Hospital of Tianjin Medical University

745474350@qq.com+86 16622080329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026